Published in Appl Res Ment Retard on January 01, 1986
Experimental analysis and extinction of self-injurious escape behavior. J Appl Behav Anal (1990) 10.02
Using parents as therapists to evaluate appropriate behavior of their children: application to a tertiary diagnostic clinic. J Appl Behav Anal (1990) 5.75
Schedule effects of noncontingent reinforcement on attention-maintained destructive behavior in identical quadruplets. J Appl Behav Anal (1994) 5.44
Functional analysis of problem behavior: a review. J Appl Behav Anal (2003) 5.12
Teacher use of descriptive analysis data to implement interventions to decrease students' problem behaviors. J Appl Behav Anal (1993) 2.53
Functional analysis of separate topographies of aberrant behavior. J Appl Behav Anal (1994) 2.01
Clinical application of functional analysis methodology. Behav Anal Pract (2008) 1.83
Functional analysis and treatment of self-injurious behavior in young children a summary of 30 cases. J Appl Behav Anal (2003) 1.32
The significance and future of functional analysis methodologies. J Appl Behav Anal (1994) 1.27
Initial functional analysis outcomes and modifications in pursuit of differentiation: a summary of 176 inpatient cases. J Appl Behav Anal (2013) 0.88
The effects of reinforcement magnitude on functional analysis outcomes. J Appl Behav Anal (2005) 0.80
Functional analysis of problem behavior: A systematic approach for identifying idiosyncratic variables. J Appl Behav Anal (2015) 0.77
Alterations to functional analysis methodology to clarify the functions of low rate, high intensity problem behavior. Behav Anal Pract (2012) 0.75
Assessment of stimulus preference and reinforcer value with profoundly retarded individuals. J Appl Behav Anal (1985) 20.12
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood (1996) 13.35
The biology of chronic myeloid leukemia. N Engl J Med (1999) 4.80
Basic research needed for stimulating the development of behavioral technologies. J Exp Anal Behav (1994) 4.16
Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem (1999) 3.95
Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J (1998) 3.63
Impulsivity in students with serious emotional disturbance: the interactive effects of reinforcer rate, delay, and quality. J Appl Behav Anal (1993) 3.60
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol (2000) 3.50
Pyramidal training: a large-scale application with institutional staff. J Appl Behav Anal (1982) 3.35
The momentum of human behavior in a natural setting. J Exp Anal Behav (1990) 3.13
The mortality of elder mistreatment. JAMA (1998) 3.11
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol (1998) 3.06
Teaching pedestrian skills to retarded persons: generalization from the classroom to the natural environment. J Appl Behav Anal (1977) 2.99
Identification and modification of a response-class hierarchy. J Appl Behav Anal (1995) 2.87
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol (1999) 2.76
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate. Leukemia (2006) 2.66
The effects of interspersal training versus high-density reinforcement on spelling acquisition and retention. J Appl Behav Anal (1980) 2.63
Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol (2000) 2.61
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia (2003) 2.60
Public transportation training: in vivo versus classroom instruction. J Appl Behav Anal (1978) 2.56
Teacher use of descriptive analysis data to implement interventions to decrease students' problem behaviors. J Appl Behav Anal (1993) 2.53
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood (2000) 2.53
Risk factors for reported elder abuse and neglect: a nine-year observational cohort study. Gerontologist (1997) 2.41
Effectiveness of brief time-out with and without contingent delay: a comparative analysis. J Appl Behav Anal (1986) 2.36
The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. Proc Natl Acad Sci U S A (1996) 2.32
Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ (2001) 2.23
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood (2001) 2.14
Stimulus fading as treatment for obscenity in a brain-injured adult. J Appl Behav Anal (1994) 2.11
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. N Engl J Med (1993) 2.09
Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol (1999) 2.06
Assessment and treatment of multiple behavior problems exhibited by a profoundly retarded adolescent. J Behav Ther Exp Psychiatry (1986) 2.05
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia. Leuk Lymphoma (2002) 2.04
Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acid. Leuk Lymphoma (1994) 2.04
Evaluating a supervision program for developing and maintaining therapeutic staff-resident interactions during institutional care routines. J Appl Behav Anal (1981) 1.99
Three-dimensional binary superlattices of magnetic nanocrystals and semiconductor quantum dots. Nature (2003) 1.94
ERV3, a full-length human endogenous provirus: chromosomal localization and evolutionary relationships. Virology (1984) 1.92
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood (1998) 1.91
Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy. Cancer (1999) 1.90
Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addiction (2004) 1.74
Analysis of demand conditions associated with reluctant speech. J Behav Ther Exp Psychiatry (1986) 1.72
Treatment of myelogenous leukemia: current status and investigational options. Blood (1996) 1.70
Characterization of the WIDR: a human colon carcinoma cell line. In Vitro (1979) 1.69
Functional analysis and treatment of severe pica. J Appl Behav Anal (1986) 1.65
Teaching self-catheterization skills to children with neurogenic bladder complications. J Appl Behav Anal (1989) 1.64
Helix handedness of Leptospira interrogans as determined by scanning electron microscopy. J Bacteriol (1979) 1.63
Analysis of demand conditions associated with stereotypy. J Behav Ther Exp Psychiatry (1987) 1.61
Emergency medicine resident work productivity in an academic emergency department. Acad Emerg Med (2000) 1.57
Movement of antibody-coated latex beads attached to the spirochete Leptospira interrogans. Proc Natl Acad Sci U S A (1981) 1.56
Structure, tissue distribution and genomic organization of the murine RRM-type RNA binding proteins TIA-1 and TIAR. Nucleic Acids Res (1996) 1.56
Methylation of the ABL1 promoter in chronic myelogenous leukemia: lack of prognostic significance. Blood (1999) 1.55
The use of a posterior lip augmentation device for a revision of recurrent dislocation after primary cemented Charnley/Charnley Elite total hip replacement: results at a mean follow-up of six years and nine months. J Bone Joint Surg Br (2007) 1.52
Management of hospital outbreaks of gastro-enteritis due to small roundstructured viruses. J Hosp Infect (2000) 1.52
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia. J Clin Oncol (1999) 1.51
Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL). Leuk Res (2001) 1.51
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration. Leukemia (2012) 1.49
Septic arthritis after arthroscopic anterior cruciate ligament reconstruction. Diagnosis and management. Am J Sports Med (1997) 1.49
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.48
Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service. Ann Intern Med (1995) 1.48
Does application of Monsel's solution after loop diathermy excision of the transformation zone reduce post operative discharge? Results of a prospective randomised controlled trial. Br J Obstet Gynaecol (1992) 1.45
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma (1993) 1.45
Cloning, characterization, expression, and chromosomal localization of a human ferritin heavy-chain gene. Proc Natl Acad Sci U S A (1986) 1.44
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood (2001) 1.43
Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study. Pain (2007) 1.42
A common, symptom-based case definition for gastroenteritis. Epidemiol Infect (2007) 1.41
Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia. Am J Med (1992) 1.41
Plasma as a source of mRNA for determining IgV(H) mutation status in patients with chronic lymphocytic leukaemia. Br J Haematol (2006) 1.40
Quantification of power Doppler energy and its future potential. Fertil Steril (2001) 1.35
Growth stimulation of human diploid fibro-blasts by the tumor promoter, 12-0-tetradecanoly-phorbol-13-acetate. Int J Cancer (1974) 1.33
Behavior management of feeding disturbances in urea cycle and organic acid disorders. J Pediatr (1987) 1.29
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution. Leukemia (2009) 1.28
The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States. Clin Biochem (2011) 1.26
Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci U S A (1996) 1.25
Functional analysis and intervention for breath holding. J Appl Behav Anal (1995) 1.23
BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia. Clin Cancer Res (2000) 1.22
Improving needed food intake of profoundly handicapped children through effective supervision of institutional staff. Appl Res Ment Retard (1981) 1.22
Teaching the handicapped to eat in public places: acquisition, generalization and maintenance of restaurant skills. J Appl Behav Anal (1981) 1.22
Richter's syndrome: a report on 39 patients. J Clin Oncol (1993) 1.19
Can syndromic surveillance data detect local outbreaks of communicable disease? A model using a historical cryptosporidiosis outbreak. Epidemiol Infect (2006) 1.19
Gonadotropin-inhibitory hormone in Gambel's white-crowned sparrow (Zonotrichia leucophrys gambelii): cDNA identification, transcript localization and functional effects in laboratory and field experiments. J Endocrinol (2004) 1.17
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol (1990) 1.16
Assessing independent and interactive effects of behavioral and pharmacologic interventions for a client with dual diagnoses. J Behav Ther Exp Psychiatry (1989) 1.14
Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL). Leukemia (2002) 1.13
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. J Clin Oncol (1991) 1.13
Use of polymerase chain reaction for rapid detection of gene insertions in whole yeast cells. Nucleic Acids Res (1991) 1.13
Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol (1995) 1.11
Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to work. Blood (1997) 1.10
Older adults. An 11-year longitudinal study of adult protective service use. Arch Intern Med (1996) 1.09
Enhanced surveillance of campylobacter infection in the North West of England 1997-1999. J Infect (2003) 1.09
Sentinel Surveillance: an option for surveillance of infectious intestinal disease. Euro Surveill (2007) 1.08